Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             468 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abdominal-pelvic lymphoproliferative disease after lung transplantation Hachem, R.R
2003
22 1S p. S194-
1 p.
artikel
2 Abstract reviewers 2003
22 1S p. S3-S5
3 p.
artikel
3 Accuracy of exhaled nitric oxide (eNO) measurements for the diagnosis of chronic rejection (CR) after lung transplantation (LTx) Verleden, G.M
2003
22 1S p. S182-S183
2 p.
artikel
4 A community-based weight management program for cardiac transplant recipients: results of a pilot study Salyer, J.J
2003
22 1S p. S130-S131
2 p.
artikel
5 A comparison of the efficacy of standard versus intermittent dosing of Rabbitt Anti-Thymocyte Globulin (RATG) for induction of heart transplant recipients Shimamoto, P.L
2003
22 1S p. S123-
1 p.
artikel
6 Activation of the classic complement cascade sequence in patients undergoing lung transplantation with and without antithymocyte globulin induction: a comparative study Pope-Harman, A
2003
22 1S p. S120-S121
2 p.
artikel
7 Acute and short-term hemodynamic and clinical effect of sildenafil in pulmonary arterial hypertension McGoon, M.D
2003
22 1S p. S153-
1 p.
artikel
8 Adherence to self-monitoring protocols after lung transplant Rea, J.B
2003
22 1S p. S131-
1 p.
artikel
9 Advances in preclinical cardiac xenotransplantation McGregor, C.G
2003
22 1S p. S89-
1 p.
artikel
10 Aerosol cyclosporine provides dose dependent improvement in lung function after lung transplantation Corcoran, T.E
2003
22 1S p. S77-
1 p.
artikel
11 Aerosolized cyclosporine as an alternative immunosuppressant in post lung transplant lymphoproliferative disease Gilbert, S
2003
22 1S p. S185-
1 p.
artikel
12 Airborne transfer of pediatric patients on extracorporeal membrane oxygenator support Fiser, W.P
2003
22 1S p. S134-
1 p.
artikel
13 Air trapping in heart-lung transplant recipients: variability of anatomical distribution and extent on sequential expiratory thin-section CT Bankier, A.A
2003
22 1S p. S186-S187
2 p.
artikel
14 A longitudinal perspective on neurodevelomental outcome following infant cardiac transplantation Freier, M.C.
2003
22 1S p. S145-
1 p.
artikel
15 A new technique for assessing myocardial improvement using pressure-volume loops during mechanical circulatory assistance Kadipasaoglu, K.A
2003
22 1S p. S199-
1 p.
artikel
16 A novel selective inhibitor of jnk suppresses alloreactivity and prolongs cardiac allograft survival Morikawa, M
2003
22 1S p. S94-
1 p.
artikel
17 A novel sub-population of bone marrow derived myocardial stem cells: potential autologus cell therapy in myocardial infarction Soukiasian, H.J
2003
22 1S p. S79-S80
2 p.
artikel
18 Anti-CD25 antibody (BASILIXIMAB) therapy is not superior to anti-thymocyte globuline (ATG) for immunosuppression induction following heart transplantation Fischer, S
2003
22 1S p. S122-
1 p.
artikel
19 Antifungal management after lung transplantation (TX): a survey of 37 transplant centers Dummer, S
2003
22 1S p. S185-
1 p.
artikel
20 Apoptotic death of infiltrating cells in human cardiac allografts is regulated by IL-2 de Groot-Kruseman, H.A
2003
22 1S p. S97-
1 p.
artikel
21 A retrospective analysis of 2 years experience using basiliximab (BMAB) in high risk lung transplant recipients(LTR) at a single institution Levvey, B.J
2003
22 1S p. S151-
1 p.
artikel
22 Are we listing the right children for heart transplant at the right time? Are we improving ? OKeeffe, J.J
2003
22 1S p. S176-S177
2 p.
artikel
23 A simple clinical predictive model for primary graft failure following lung transplantation Christie, J.D
2003
22 1S p. S160-
1 p.
artikel
24 Aspects of adherence to the treatment regimen following heart or heart-lung transplantation in young people Wray, J.C
2003
22 1S p. S130-
1 p.
artikel
25 Assessment of myocardial blood flow and coronary bypass graft patency during LVAD support Maybaum, S
2003
22 1S p. S211-
1 p.
artikel
26 Assessment of the phenotypic profile and T cell clonality in biopsies of lung allograft rejection Pope-Harman, A
2003
22 1S p. S137-
1 p.
artikel
27 Asthma donors are not a contraindication for lung transplantation(LTX): a 12 year single centre experience Griffiths, A.P
2003
22 1S p. S111-S112
2 p.
artikel
28 Atrioventricular orthotopic heart transplantation: long term follow up of a prospective randomised clinical trial Jansz, P.C
2003
22 1S p. S171-
1 p.
artikel
29 Autologous skeletal myoblasts transplanted to infarcted human myocardium: histological analysis of cell survival and differentiation Pagani, F.D
2003
22 1S p. S78-S79
2 p.
artikel
30 Autopsy Pathology (AP) in primate recipients of heterotopic xenografts (XG) functioning for >60 days Tazelaar, H.D
2003
22 1S p. S138-
1 p.
artikel
31 Azathioprine/Mycophenolate conversion in the management of Bronchiolitis Obliterans Syndrome (BOS) following (heart-)lung transplantation Dupont, L.J
2003
22 1S p. S123-
1 p.
artikel
32 Blockade of receptor for age (RAGE) suppresses T lymphocyte proliferation in mixed lymphocyte culture Moser, B
2003
22 1S p. S100-
1 p.
artikel
33 B-Natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery Tann, S.M
2003
22 1S p. S157-
1 p.
artikel
34 Bone marrow cell enhances the efficacy of skeletal myoblast transplantation in rats with ischemic cardiomyopathy Sakaguchi, G
2003
22 1S p. S79-
1 p.
artikel
35 Bone marrow inhibits allospecific T cell proliferation and clonal expansion George, J.F
2003
22 1S p. S104-
1 p.
artikel
36 Bone marrow mononuclear cell transplantation improved cardiac function of rat doxorubicin-induced cardiomyopathy model Ishida, M
2003
22 1S p. S124-S125
2 p.
artikel
37 Brain natriuretic peptide predicts rejection in heart transplant recipients independent of pulmonary capillary wedge pressure Wu, A.H
2003
22 1S p. S165-
1 p.
artikel
38 Bridge to cardiac transplantation: comparison of LVAD versus inotropic support Moffatt, S.D
2003
22 1S p. S207-
1 p.
artikel
39 Bridge to heart transplant with the continuos axial flow debakey VAD E Lanfranconi, M
2003
22 1S p. S204-
1 p.
artikel
40 Bronchiolitis obliterans syndrome/obliterative bronchiolitis ameliorated by azithromycin Gerhardt, S.G
2003
22 1S p. S78-
1 p.
artikel
41 Calcineurin-inhibitor-free immunosuppression with mycophenolatmofetil and sirolimus after cardiac transplantation is safe and improves renal function significantly Groetzner, J
2003
22 1S p. S150-S151
2 p.
artikel
42 Can changes over time in echocardiographic measurements; cardiopulmonary exercise testing and radionuclide ventriculography predict outcome in patients with chronic heart failure? Stempfle, H.-U
2003
22 1S p. S107-
1 p.
artikel
43 Cardiac angiotensin II receptors predict allograft vasculopathy in heart transplant recipients Yousufuddin, M
2003
22 1S p. S165-
1 p.
artikel
44 Cardiac pathology in porcine to primate heterotopic xenografts (XG) functioning for >60 days Tazelaar, H.D
2003
22 1S p. S137-S138
2 p.
artikel
45 Cardiac rhythm during and after explantation of left ventricular assist devices (LVAD) using the harefield recovery programme Hardy, J
2003
22 1S p. S202-S203
2 p.
artikel
46 Cardiac transplantation for the treatment of adults with congenital heart disease: a single center experience Pinney, S.P
2003
22 1S p. S179-
1 p.
artikel
47 Cardiac transplantation without prospective crossmatch in HLA-sensitized ventricular assist device patients Etoch, S.W
2003
22 1S p. S149-
1 p.
artikel
48 Cardiopulmonary bypass does not increase the morbidity associated with lung transplantation for chronic obstructive airway disease Jansz, P.C
2003
22 1S p. S190-
1 p.
artikel
49 Carvedilol in children with cardiomyopathy: 2 years follow up in a single institution Rusconi, P
2003
22 1S p. S135-
1 p.
artikel
50 Causes of death after heart transplantation and risk factor analysis Angelini, A
2003
22 1S p. S138-S139
2 p.
artikel
51 C4D as a diagnostic adjunct in lung allograft biopsies Pope-Harman, A
2003
22 1S p. S103-
1 p.
artikel
52 Cellular cardiomyoplasty using skeletal myoblasts overexpressing iL-1 receptor antagonist enhances effects on adverse post-infarction remodeling Murtuza, B
2003
22 1S p. S80-
1 p.
artikel
53 Cerebral hyperperfusion syndrome following LVAD implantation Boyle, A.J
2003
22 1S p. S203-
1 p.
artikel
54 Changes in collagen content of the myocardium by unloading with a cardiac assist device Mueller, J
2003
22 1S p. S195-
1 p.
artikel
55 Changes in the coronary artery adventitial microvascular density may be involved in the pathogenesis of coronary artery vasculopathy Atkinson, C
2003
22 1S p. S136-
1 p.
artikel
56 Characterization of regulatory CD8+CD28- T cells in heart transplant recipients Colovai, A.I
2003
22 1S p. S106-
1 p.
artikel
57 Chemokine receptor expression on BAL lymphocytes isolated from lung transplant recipients Medoff, B.D
2003
22 1S p. S100-
1 p.
artikel
58 Chronic therapy with the Acorn Cardiac Support Device normalizes gene expression of vascular endothelial and basic fibroblast growth factors in dogs with heart failure Rastogi, S
2003
22 1S p. S218-
1 p.
artikel
59 Chronotropic reserve beyond anerobic threshold (CRAT) predicts survival in advanced heart failure Mehra, M.R
2003
22 1S p. S86-
1 p.
artikel
60 Clinical predictors of improvement in ventricular function in non-ischemic dilated cardiomyopathy Ahmed, S
2003
22 1S p. S172-
1 p.
artikel
61 Clinical results with eptfe inflow conduit for mechanical circulatory support Mussivand, T
2003
22 1S p. S84-
1 p.
artikel
62 Clonally-expanded gamma-chain TCR transcripts are present in the coronary arteries of cardiac allografts from patients with chronic rejection Jung, W.J
2003
22 1S p. S105-S106
2 p.
artikel
63 Co-localisation of MMP-9 (gelatinase B) with airway neutrophils in stable lung transplant recipients-A potential role in the bronchiolitis obliterans syndrome Forrest, I.A
2003
22 1S p. S184-
1 p.
artikel
64 Combined prophylaxis of CMV-immune globulin plus ganciclovir versus CMV-immune globulin alone in high risk heart transplant recipients Bonaros, N.E
2003
22 1S p. S156-
1 p.
artikel
65 Comparison of quantitative PCR to antigenemia for CMV surveillance after lung transplantation Cahill, B.C
2003
22 1S p. S184-
1 p.
artikel
66 Comparison of survival by allocation to medical therapy, surgery or heart transplantation for ischaemic advanced heart failure Lim, E
2003
22 1S p. S166-
1 p.
artikel
67 Comparison of the calcium sensitizer levosimendan and prostaglandin E1 as a bridge to increased beta - blockade in patients with refractory, decompensated chronic heart failure Berger, R
2003
22 1S p. S110-
1 p.
artikel
68 Compliance behaviors of elderly patients with advanced heart failure Evangelista, L.S
2003
22 1S p. S127-S128
2 p.
artikel
69 Continuing medical education information 2003
22 1S p. S6-S7
2 p.
artikel
70 Coronary ectasia in pediatric heart transplant recipients Kaufman, B.D
2003
22 1S p. S133-
1 p.
artikel
71 Correlation between induced sputum neutrophil percentage and decline from best postoperative baseline in FEV1, FEF25-75 and FEF50 Allen, D.J
2003
22 1S p. S192-S193
2 p.
artikel
72 Cost analysis of universal prophylaxis versus preemptive therapy for cytomegalovirus Crompton, J.A
2003
22 1S p. S187-S188
2 p.
artikel
73 C2 Targets and multivariate predictors of C2 levels in stable heart transplant patients immunosuppressed on a C0-based regimen Caforio, A.L.P
2003
22 1S p. S117-
1 p.
artikel
74 Cyclosporin C2 monotoring after lung transplantation (LT) in cystic fibrosis (CF) and non CF patients Bodin, L
2003
22 1S p. S120-
1 p.
artikel
75 Cyclosporin 2-hr post dose monitoring-a potentially valuable tool for optimising immunosuppresssion after heart transplantation Datta, S
2003
22 1S p. S124-
1 p.
artikel
76 Cyclsosporin-induced endothelial dysfunction: is tetrahydrobiopterin the solution? El-Hamamsy, I
2003
22 1S p. S98-
1 p.
artikel
77 Cystic fibrosis and lung transplantation - determination of the survival benefit Aigner, C
2003
22 1S p. S214-
1 p.
artikel
78 Cytoskeletal protein 4.1 isoforms, newly discovered in heart, are differentially overexpressed in the myocardium of patients with deteriorating heart failure Birks, E.J
2003
22 1S p. S203-S204
2 p.
artikel
79 25 days of baboons after orthotopic xenotransplantation of hDAF transgenic PIG hearts using a moderate immunosuppression Brandl, U
2003
22 1S p. S100-S101
2 p.
artikel
80 Declining adverse event and mortality rates over implant duration with the novacor LVAS: implications for destination therapy Rogers, J.G
2003
22 1S p. S196-
1 p.
artikel
81 De novo alveolar proteinosis in lung transplant recipients Bag, R.
2003
22 1S p. S139-
1 p.
artikel
82 Depression and neurocognitive deficits are common comorbid conditions in ambulatory heart failure patients Romanelli, J
2003
22 1S p. S126-
1 p.
artikel
83 Deregulation of cell cycle protein expression by constitutive overexpression of AIF-1 in human coronary artery smooth muscle cells Absaieri, M.V
2003
22 1S p. S98-
1 p.
artikel
84 Design improvements of the heartmate® VE LVAS and their effectiveness in reducing adverse events Farrar, D.J
2003
22 1S p. S83-
1 p.
artikel
85 Detection of cardiac allograft rejection by multi-parameter gene expression analysis on circulating mononuclear cells using real-time RT-PCR Schoels, M
2003
22 1S p. S97-
1 p.
artikel
86 Diagnostic accuracy of coronary angiography and risk factors for post-heart transplant Coronary Artery Vasculopathy (CAV) Sharples, L.D
2003
22 1S p. S208-
1 p.
artikel
87 Diagnostic value and safety of endomyocardial biopsy in selected patients with heart failure Howe, W.O.
2003
22 1S p. S140-
1 p.
artikel
88 Differences in patients with left ventricular assist device between dilated cardiomyopathy and dilated phase hypertrophic cardiomyopathy Fukushima, N
2003
22 1S p. S197-
1 p.
artikel
89 Different cyclosporine regimens and their influences on transplant vasculopathy Richter, M.H.C
2003
22 1S p. S95-
1 p.
artikel
90 Differential expression of the novel immuno-regulatory growth factors IL-11 and IL-17 in lung transplant recipients Zheng, L
2003
22 1S p. S98-S99
2 p.
artikel
91 Differential protein expression in plexogenic pulmonary hypertensive lung lesions Southwood, M
2003
22 1S p. S152-S153
2 p.
artikel
92 Differential regulation of CA2+-dependent atpase-activity in left ventricular myocardium during mechanical circulatory support Milting, H
2003
22 1S p. S198-
1 p.
artikel
93 Differential trafficking of tolerizing cells in neonatal tolerance induction: fate depends on cell source Lobach, N.E
2003
22 1S p. S104-
1 p.
artikel
94 Differential vulnerability to psychiatric distress after lung vs. heart transplantation Dew, M.A
2003
22 1S p. S128-
1 p.
artikel
95 Differentiation of human bone marrow mesenchymal stem cells into airway epithelia Valentine, V.G
2003
22 1S p. S125-S126
2 p.
artikel
96 Dilutional anemia in patients with advanced heart failure is associated with poor outcome Mancini, D.M
2003
22 1S p. S84-S85
2 p.
artikel
97 Distribution of collagen subtypes and matrix metalloproteinases in coronary artery vasculopathy Atkinson, C
2003
22 1S p. S97-
1 p.
artikel
98 Dobutamine stress echocardiography is predictive of events after heart transplantation Pincus, M.W
2003
22 1S p. S174-
1 p.
artikel
99 Does extended duration of mechanical circulatory support impact clinical outcomes? Mussivand, T
2003
22 1S p. S158-S159
2 p.
artikel
100 Does functional ability and return to work improve from 1 to 3 years after heart transplantation? White-Williams, C
2003
22 1S p. S219-S220
2 p.
artikel
101 Does prophylactic ganciclovir therapy after heart transplantation decrease CMV-infection properly? Mueller, M
2003
22 1S p. S157-
1 p.
artikel
102 Does QRS width really impact on cardiac resynchronization benefit in heart failure patients? Gronda, E
2003
22 1S p. S108-S109
2 p.
artikel
103 Does statin therapy added to calcium channel blocker reduce development of transplant coronary artery disease in heart transplant survivors? Gao, S.-Z
2003
22 1S p. S177-
1 p.
artikel
104 Do implantable left ventricular assist devices affect posttransplant survival in the modern era (2000-2002): an analysis of the US scientific registry of transplant recipients Aaronson, K.D
2003
22 1S p. S149-S150
2 p.
artikel
105 Donor-derived suppressor macrophages for recipient-specific immunosuppression in lung transplantation in minipigs Warnecke, G
2003
22 1S p. S81-S82
2 p.
artikel
106 Donor designation on the driver’s license: friend or foe? Kfoury, A.G
2003
22 1S p. S88-
1 p.
artikel
107 Donor intracranial bleeding is associated with advanced transplant coronary vasculopathy: evidence from intravascular ultrasound Yamani, M.H
2003
22 1S p. S76-
1 p.
artikel
108 Donor intracranial bleeding is associated with upregulation of the angiotensin receptor Yamani, M.H
2003
22 1S p. S212-
1 p.
artikel
109 Donor intracranial hemorrhage is associated with graft dysfunction and poorer survival following heart transplantation McNeill, A.M
2003
22 1S p. S112-S113
2 p.
artikel
110 Donor pretreatment using the aerosolized prostacyclin analogue iloprost optimizes postischemic function of non heart beating donor lungs Wittwer, T
2003
22 1S p. S117-
1 p.
artikel
111 Do older heart transplant recipients have a normal quality of life? Kao, A
2003
22 1S p. S129-S130
2 p.
artikel
112 Double lung transplantation does not confer a survival advantage over single lung transplanation in COPD Valapour, M
2003
22 1S p. S92-
1 p.
artikel
113 Double lung transplantation via median sternotomy and with cardiopulmonary bypass is safe and without adverse clinical outcome Dhital, K.K
2003
22 1S p. S185-
1 p.
artikel
114 Early initiation of aerobic and resistance training improves peak aerobic power, leg-press maximal strength and distance walked in six minutes in recent cardiac transplant recipients Haykowsky, M
2003
22 1S p. S179-
1 p.
artikel
115 Economic evaluation of everolimus vs. azathioprine as part of triple immunosuppressive therapy in a phase III de novo heart transplant trial Radeva, J.I
2003
22 1S p. S167-
1 p.
artikel
116 Effectivity of a T-cell adapted induction-therapy with antithymocyte globuline (ATG) sangstad Koch, A
2003
22 1S p. S168-
1 p.
artikel
117 Effect of brain death on release of brain and atrium natriuretic peptides in an animal model Potapov, E.V
2003
22 1S p. S115-
1 p.
artikel
118 Effect of folate administration on heart allograft atherosclerosis one year after transplant: a prospective randomized study Potena, L
2003
22 1S p. S75-
1 p.
artikel
119 Effect of mechanical unloading of left ventricle on right ventricular remodeling Osorio, J.C
2003
22 1S p. S199-S200
2 p.
artikel
120 Effect of mechanical ventricular unloading on mast cells in failing myocardium Skrabal, C.A
2003
22 1S p. S210-
1 p.
artikel
121 Effect of rapamycin on anti-HLA donor antibody formation in patients with transplant coronary artery disease Pinney, S.P
2003
22 1S p. S173-
1 p.
artikel
122 Effect of transplant operation on survival after development of bronchiolitis obliterans syndrome (BOS) in patients with chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) Hadjiliadis, D
2003
22 1S p. S92-S93
2 p.
artikel
123 Effects of differing calcineurin based immune therapies on homocysteine levels in cardiac transplant patients Fedoruk, L.M
2003
22 1S p. S150-
1 p.
artikel
124 Effects of FK506 inhalant on the suppression of acute rejection in lung transplantation: use of rat orthotopic lung transplantation model Ingu, A
2003
22 1S p. S95-S96
2 p.
artikel
125 Effects of P38 mitogen-activated protein kinase inhibitor as an additive to celsior solution on canine heart transplantation from non-heart-beating donors Koike, N.
2003
22 1S p. S143-
1 p.
artikel
126 Effects of porcine Gal-negative hematopoietic progenitor cells on primate platelet aggregation and endothelial cell activation - implications for the induction of mixed hematopoetic chimerism in the PIG-to-primate model Knosalla, C
2003
22 1S p. S104-S105
2 p.
artikel
127 Efficacy and safety of tacrolimus (TAC) vs. cyclosporine microemulsion (CME) in de novo cardiac transplant recipients: 6-month results Grimm, M
2003
22 1S p. S92-
1 p.
artikel
128 Efficiency of retrograde intracoronary infusion for cell transplantation to the heart Suzuki, K
2003
22 1S p. S126-
1 p.
artikel
129 Electrophysiological properties of myoblasts injected into the infarcted myocardium of rats Ott, H.C
2003
22 1S p. S79-
1 p.
artikel
130 Elevated CXCR4 levels on peripheral blood T-cells in heart transplantation patients Athanassopoulos, P
2003
22 1S p. S169-S170
2 p.
artikel
131 Elevated homocysteine levels accelerate cardiac allograft vasculopathy Kutschka, I
2003
22 1S p. S74-S75
2 p.
artikel
132 Elevated levels of the CXCR3 chemokine ligand itac is associated with the development of severe transplant coronary artery disease in humans Kao, J
2003
22 1S p. S97-S98
2 p.
artikel
133 Elevated troponin I in heart failure: a marker for poor prognosis Horwich, T.H
2003
22 1S p. S109-
1 p.
artikel
134 Emergent mechanical support in the community: improvement with early transplant center referral Morris, R.J
2003
22 1S p. S148-S149
2 p.
artikel
135 En-bloc vascularized thymus and heart transplantation in miniature swine Johnston, D.R
2003
22 1S p. S88-S89
2 p.
artikel
136 Enhanced clinical utility of de novo cyclosporin C2 monitoring after lung transplantation Morton, J.M
2003
22 1S p. S119-
1 p.
artikel
137 Enhanced immune response in CMV D+/R- heart transplant patients receiving combined CMV prophylaxis Bonaros, N.E
2003
22 1S p. S171-
1 p.
artikel
138 Equivalent survival despite higher risk profile in african american heart transplant recipients Gupta, D
2003
22 1S p. S172-
1 p.
artikel
139 Evaluation of an oral CXCR3 antagonist in a rat model of acute cardiac allograft rejection Bowdish, M.E
2003
22 1S p. S162-
1 p.
artikel
140 Evaluation of changes in functional capacity, quality of life and hospital days following participation in cardiopulmonary rehab in patients with congestive heart failure Houston-Feenstra, L
2003
22 1S p. S107-
1 p.
artikel
141 Everolimus dose recommendations in de novo heart transplantation - TDM simulations Starling, R.C.
2003
22 1S p. S140-
1 p.
artikel
142 Everolimus in de novo cardiac transplant recipients: 24-month follow-up Haverich, A.
2003
22 1S p. S140-S141
2 p.
artikel
143 Everolimus is associated with a reduced incidence of CMV infection in heart transplantation Dorent, R.
2003
22 1S p. S141-S142
2 p.
artikel
144 Exercise assessment in children after cardiac transplant in infancy: effect of chronotropic incompetence Abarbanell, G.L.
2003
22 1S p. S144-
1 p.
artikel
145 Exogenous surfactant instillation in lung donors to reduce early graft dysfunction Strueber, M.
2003
22 1S p. S142-
1 p.
artikel
146 Experience of severe fulminant myocarditis with shock by extracorporeal membrane oxygenation - what mechanical support should be considered first? Chen, Y.S
2003
22 1S p. S211-S212
2 p.
artikel
147 Expression of allograft inflammatory factor-1 in T-lymphocytes: a role in T-cell activation and allograft rejection Kelemen, S.E
2003
22 1S p. S102-
1 p.
artikel
148 Expression of connective tissue growth factor is upregulated in post-transplant obliterative airway disease Thanikachalam, M
2003
22 1S p. S101-
1 p.
artikel
149 Extracorporeal membrane oxygenation (ECMO) as a bridge to heart transplantation in children Perez, R
2003
22 1S p. S215-
1 p.
artikel
150 Factors influencing mycophenolate mofetil drug exposure in thoracic organ transplant recipients Partovi, N
2003
22 1S p. S121-
1 p.
artikel
151 Fk 778, a novel immunosuppressive agent reduces early adhesion molecule upregulation after cardiac transplantation Deuse, T
2003
22 1S p. S94-S95
2 p.
artikel
152 Full viability of the myocardium after twenty-four hour organ conservation Martin, J
2003
22 1S p. S114-
1 p.
artikel
153 Functional outcomes of lobar and double lung transplant recipients Rodrigues, J.S
2003
22 1S p. S93-
1 p.
artikel
154 Functional recovery of heart failure patients in cardiogenic shock treated with paracorporeal biventricular support Vogel, C.N
2003
22 1S p. S126-S127
2 p.
artikel
155 Gamma-interferon-dependent T cell-mediated injury and remodeling of human coronary arteries Wang, Y
2003
22 1S p. S154-S155
2 p.
artikel
156 Gene expression in cardiac and lung xenografts Waddell, T.K
2003
22 1S p. S90-
1 p.
artikel
157 General meeting information 2003
22 1S p. S8-S9
2 p.
artikel
158 Geometric disproportion of cardiac structures affects atrioventricular valve insufficiency in neonatal cardiac transplant Asano, M
2003
22 1S p. S135-
1 p.
artikel
159 Granzyme B, a cytotoxic immune protease, induces apoptosis of smooth muscle cells in the absence of perforin Choy, J.C
2003
22 1S p. S155-
1 p.
artikel
160 Growth hormone therapy following pediatric cardiac transplantation Mital, S
2003
22 1S p. S215-
1 p.
artikel
161 Health related quality of life of elderly patients with end-stage heart failure Doering, L.V
2003
22 1S p. S128-
1 p.
artikel
162 Health-related quality of life outcomes in patients with pulmonary hypertension Shafazand, S
2003
22 1S p. S185-S186
2 p.
artikel
163 Heart failure demands more biventricular mechanical circulatory support Sapirstein, J.S
2003
22 1S p. S148-
1 p.
artikel
164 Heart failure survival score continues to predict death or unos 1 transplant in heart failure patients receiving beta blockers Koelling, T.M
2003
22 1S p. S216-
1 p.
artikel
165 Hearts transfected with inducible nitric oxide synthase have accelerated restoration of cardiac function following ischemia/reperfusion associated with cardiac transplantation Shears, L.L.
2003
22 1S p. S143-S144
2 p.
artikel
166 Heart transplantation in diabetic recipients: a decade review of 161 patients at columbia presbyterian Morgan, J.A
2003
22 1S p. S209-S210
2 p.
artikel
167 Heart transplant in recipients older than 60 years. insights after more than 10 years of follow-up Segovia, J
2003
22 1S p. S168-S169
2 p.
artikel
168 Hemodynamic impact of biventricular pacing in candidates for heart transplantation Naegele, H
2003
22 1S p. S109-
1 p.
artikel
169 Highlights of the scientific program 2003
22 1S p. S10-S12
3 p.
artikel
170 High potassium lung preservation solutions increase production of NADPH oxidase-dependent reactive oxygen species Murar, J
2003
22 1S p. S101-S102
2 p.
artikel
171 Hormonal therapy stabilizes hemodynamics during donor procurement Van Bakel, A.B.
2003
22 1S p. S142-
1 p.
artikel
172 Hotel rates and cancellation policy 2003
22 1S p. S18-
1 p.
artikel
173 Housing registration form 2003
22 1S p. S17-
1 p.
artikel
174 How to improve organ donation: the results of the ISHLT/FACT poll Kherani, A.R
2003
22 1S p. S127-
1 p.
artikel
175 How to predict forced vital capacity of the recipient after living-donor lobar lung transplantation Date, H
2003
22 1S p. S181-
1 p.
artikel
176 Human umbilical cord cells for tissue engineering of trileaflet heart valves Kadner, A
2003
22 1S p. S125-
1 p.
artikel
177 Hypogammaglobulinemia in pediatric lung transplant recipients is associated with increase mortality De la Morena, M.T
2003
22 1S p. S132-S133
2 p.
artikel
178 Identification of MIP-1β and VE-Cadherin as important markers of acute rejection following human heart transplantation Roussoulieres, A.L.S
2003
22 1S p. S178-
1 p.
artikel
179 Identifying optimal heart failure patients for forced titration of vasodilator threapy despite “low” initial systolic blood pressures: a cardiac bioimpedance study Saltzberg, M.T
2003
22 1S p. S167-
1 p.
artikel
180 Idiopathic dilated cardiomyopathy a major predisposing factor for early rejection: relevance to outcome Warraich, R.S
2003
22 1S p. S167-
1 p.
artikel
181 IL-6 and TNFα cytokine genotypes are associated with acute rejection and lower survival in African American heart transplant recipients Coleman, B.L
2003
22 1S p. S216-S217
2 p.
artikel
182 IL-10 high genotype is protective against acute persistent rejection after lung transplantation Zheng, H.X
2003
22 1S p. S77-S78
2 p.
artikel
183 IL-1β in broncho-alveolar lavage is a non-invasive predictor of the viability of the pulmonary graft from the non-heart-beating donor Rega, F
2003
22 1S p. S213-
1 p.
artikel
184 IL-10 induces suppressor of cytokine secretion-3 (SOCS-3) and ILT-3 in human endothelial cells and inhibits T cell costimulation Gleissner, C
2003
22 1S p. S81-
1 p.
artikel
185 Immunology properties of rat vascular endothelium Riha, M
2003
22 1S p. S107-
1 p.
artikel
186 Immunosuppressive effects of FK506 inhalant on acute rejection in lung transplantation Ingu, A
2003
22 1S p. S121-
1 p.
artikel
187 Impact of anticoagulant and antiplatelet regimens on graft survival in PIG-to-primate cardiac xenotransplantation Schirmer, J.M
2003
22 1S p. S102-S103
2 p.
artikel
188 Impact of BMI on long-term survival after heart transplantation Eisen, H.J
2003
22 1S p. S170-
1 p.
artikel
189 Impact of bronchogenic carcinoma in patients undergoing lung transplantation. results of an international survey de Perrot, M
2003
22 1S p. S161-
1 p.
artikel
190 Impact of donor characteristics in pediatric heart transplant recipients Lamour, J.M
2003
22 1S p. S133-
1 p.
artikel
191 Impact of donor serum sodium levels on outcome after heart transplantation Kaczmarek, I
2003
22 1S p. S111-
1 p.
artikel
192 Impact of donor smoking on survival after lung transplantation Waddell, T.K
2003
22 1S p. S114-S115
2 p.
artikel
193 Impact of donor-transmitted coronary atherosclerosis Grauhan, O
2003
22 1S p. S213-S214
2 p.
artikel
194 Impact of health insurance and black race on outcome after cardiac transplantation: analysis of the cardiac transplant research database Montpetit, M.C
2003
22 1S p. S208-S209
2 p.
artikel
195 Impact of new therapies on the prevalence of coronary artery disease in heart transplant survivors: stanford experience Gao, S.-Z
2003
22 1S p. S173-
1 p.
artikel
196 Impact of post-transplant antibody in a re-examination of humoral rejection diagnosis Takemoto, S.K
2003
22 1S p. S170-S171
2 p.
artikel
197 Implantable cardioverter defibrillators in heart transplant patients at risk for sudden death: shocking news? Cogert, G.A
2003
22 1S p. S178-S179
2 p.
artikel
198 Implantation of a cardiac support device as adjunct to CABG in ischemic cardiomyopathy Castel, M.A
2003
22 1S p. S158-
1 p.
artikel
199 Improved overall outcome with the micromed debakey LVAD as bridge to transplant Salzberg, S
2003
22 1S p. S206-
1 p.
artikel
200 Improved right ventricular structure following LVAD support in patients with end-stage cardiomyopathy Kucuker, S.A
2003
22 1S p. S211-
1 p.
artikel
201 Improved survival after diagnosis of cardiac allograft vasculopathy (CAV) through extreme reduction of cholesterol and fibrinogen Jaeger, B.R.
2003
22 1S p. S75-
1 p.
artikel
202 Improved survival with statin therapy in ischemic and non-ischemic heart failure Horwich, T.B
2003
22 1S p. S159-
1 p.
artikel
203 Incidence and outcome of malignancies in patients after heart transplantation Ruzicka, M
2003
22 1S p. S168-
1 p.
artikel
204 Incidence of non-cellular (humoral) rejection unchanged in the 1990 decade despite a decrease in cellular rejection Cogert, G.A
2003
22 1S p. S119-S120
2 p.
artikel
205 Incidence of right ventricular failure and the role of concomitant coronary revascularization during LVAD implantation Park, S.J
2003
22 1S p. S200-
1 p.
artikel
206 Increased expression of CD40, B7–2, interleukin-15 and granzyme B in bronchoalveolar lavage cells from human lung transplant recipients Mohanakumar, T
2003
22 1S p. S186-
1 p.
artikel
207 Increased expression of single-strand DNA-binding proteins represses alpha-myosin heavy chain (MHC) gene expression in heart failure Raman, J
2003
22 1S p. S106-
1 p.
artikel
208 Increased incidence of severe lung allograft acute rejection in patients exhibiting HLA-specific antibodies Zeevi, A
2003
22 1S p. S162-S163
2 p.
artikel
209 Increased thoracic organ ultilization using an advanced practice organ procurement coordinator Babcock, W.D
2003
22 1S p. S88-
1 p.
artikel
210 Index to authors of abstracts 2003
22 1S p. S222-S234
13 p.
artikel
211 Indirect allorecognition of MHC class II peptides accellerates cardiac allograft rejection in miniature swine Johnston, D.R
2003
22 1S p. S82-
1 p.
artikel
212 Induction of tolerance to a minor histocompatibility antigen prevents post-transplant obliterative airway disease in mouse tracheal allografts Mohanakumar, T
2003
22 1S p. S82-
1 p.
artikel
213 Induction therapy with two doses of daclizumab in heart transplantation: a prospective, multi centric clinical study. interim analysis Rabago, G
2003
22 1S p. S123-
1 p.
artikel
214 Infection in permanent circulatory support: experience from the randomized evaluation of mechanical assistance in the treatment of congestive heart failure (rematch) trial Holman, W
2003
22 1S p. S82-S83
2 p.
artikel
215 Infectious complications in heart transplantation are influenced by ethnic disparities in immunoglobulin expression Mehra, M.R
2003
22 1S p. S175-
1 p.
artikel
216 Inflammatory markers in BAL and breath condensate early and late after lung transplantation Hofer, M
2003
22 1S p. S188-S189
2 p.
artikel
217 Influence of an anti-CD25 mAB on tolerance induction through BMT with costimulation blockade Bigenzahn, S
2003
22 1S p. S81-
1 p.
artikel
218 Inhaled iloprost as a bridge to transplant in advanced pulmonary fibrosis and secondary pulmonary hypertension Moloney, E.D
2003
22 1S p. S194-
1 p.
artikel
219 Inhaled milrinone and prostacyclin for ventricular assist device recipients: effectiveness and cost Etoch, S.W
2003
22 1S p. S149-
1 p.
artikel
220 Inhibition of human NK cell mediated cytotxicity to pig endothelial cells by over expression of human ecto-5′-nucleotidase Osborne, F.N
2003
22 1S p. S90-
1 p.
artikel
221 Inhibition of poly-ADP ribose synthase (PARS) increases cardiac myocyte survival during acute cardiac allograft rejection in rats Szabolcs, M.J
2003
22 1S p. S105-
1 p.
artikel
222 Inhibition of poly (ADP) ribose synthetase ameliorates experimental obliterative bronchiolitis in rat tracheal allografts Farivar, A.S
2003
22 1S p. S155-
1 p.
artikel
223 Initial clinical experience with the thoratec IVAD: a versatile implantable UNI- or BI-ventricular assist device Tsui, S
2003
22 1S p. S201-
1 p.
artikel
224 Initial European experience with the lionheart(TM) LVAS (Left Ventricular Assist System)for destination therapy Pae, W.E
2003
22 1S p. S83-
1 p.
artikel
225 iNOS and peroxynitrite formation during acute rejection after human heart transplantation Birks, E.J
2003
22 1S p. S137-
1 p.
artikel
226 Interleukin-4 and -10 combined gene therapy induces cardiac allograft tolerance by promoting the alloreactive T cells apoptosis and preventing myocytes apoptosis via Fas/FasL pathway Furukawa, H
2003
22 1S p. S80-S81
2 p.
artikel
227 Interleukin-6 and risk of coronary artery disease and graft failure in heart transplant recipients Labarrere, C.A
2003
22 1S p. S164-
1 p.
artikel
228 Interleukin-6 is the most potent predictor for worsening of heart failure in patients with congestive heart failure Gwechenberger, M
2003
22 1S p. S85-S86
2 p.
artikel
229 International society for heart and lung transplantation 2003
22 1S p. S1-
1 p.
artikel
230 Inter-observer variability in grading acute rejection in endomyocardial biopsies Lindop, G.B.M
2003
22 1S p. S96-
1 p.
artikel
231 Inter-reader and intra-reader agreement for grading acute rejection and airway inflammation after lung transplantation, based on the lung rejection study group revised working formulation Chakinala, M.M
2003
22 1S p. S96-
1 p.
artikel
232 Intracoronary interferon-γ promotes vasculopathy in tolerant miniature swine bearing mhc class I disparate hearts Hoerbelt, R
2003
22 1S p. S102-
1 p.
artikel
233 Intravenous ribavirin : effective therapy for respiratory syncytial virus (RSV) infection after lung transplantation Scott, A.R
2003
22 1S p. S192-
1 p.
artikel
234 Is acute rejection primary in the development of obliterative bronchiolitis? a retrospective study of daclizumab and thymoglobulin Conte, J.V
2003
22 1S p. S122-
1 p.
artikel
235 Ischemic reperfusion injury to donor lung endothelium is mediated through gene promoter NF-KB and upstream IKK kinase Bhullar, I.S
2003
22 1S p. S115-
1 p.
artikel
236 ISHLT Registration form 2003
22 1S p. S15-
1 p.
artikel
237 ISHLT registration policies 2003
22 1S p. S16-
1 p.
artikel
238 ISHLT tour descriptions/dates/prices 2003
22 1S p. S20-S22
3 p.
artikel
239 ISHLT tour registration form 2003
22 1S p. S19-
1 p.
artikel
240 Is interstitial lung disease a risk factor for mortality in pediatric lung transplantion? Guleserian, K.J
2003
22 1S p. S215-S216
2 p.
artikel
241 Is invasive fungal disease in lung transplant recipients predictable? Plit, M.L
2003
22 1S p. S193-
1 p.
artikel
242 Is low frequency of donor specific interleukin 10 (IL10) producing cells in peripheral blood (PB) of heart transplant recipients related to graft rejection? Paschetto, E
2003
22 1S p. S164-S165
2 p.
artikel
243 Is recrudescent tobacco exposure following heart transplantation associated with expression of atherothrombosis risk markers? Mehra, M.R
2003
22 1S p. S178-
1 p.
artikel
244 Is the alternate waiting list too high risk? The columbia-presbyterian experience Chen, J.M
2003
22 1S p. S175-
1 p.
artikel
245 Is there a need for a tailored immunosuppression in elderly heart transplant recipients? Kaczmarek, I
2003
22 1S p. S217-
1 p.
artikel
246 ITO and IR potassium channel (K+) expression and regulation during severe left ventricular dysfunction (LVD) and ventricular unloading Maybaum, S
2003
22 1S p. S200-
1 p.
artikel
247 L-Arginine improves endothelial and myocardial function after brain death Szabo, G
2003
22 1S p. S113-S114
2 p.
artikel
248 Late cardiac allograft rejection ISHLT grade ≥3A resolves spontaneously and is not subject to an era effect Klingenberg, R
2003
22 1S p. S136-S137
2 p.
artikel
249 Left ventricular assist device replacement Long, J.W
2003
22 1S p. S83-S84
2 p.
artikel
250 Left ventricular mechanical unloading decreases ischemic susceptibility by modulating angiotensin II type-2 receptor gene experssion in the failing heart after myocardial infarction Horimoto, S
2003
22 1S p. S197-
1 p.
artikel
251 Left ventricular shape change with myosplint® implantation in dilative cardiomyopathy: clinical experience in 9 patients Rahmel, A
2003
22 1S p. S158-
1 p.
artikel
252 Liberalization of donor criteria does not compromise outcomes three years after lung transplantation Bhorade, S.M
2003
22 1S p. S212-S213
2 p.
artikel
253 Liver failure following mechanical circulatory support: improving outcome with application of MARS technique El-Banayosy, A
2003
22 1S p. S219-
1 p.
artikel
254 Lobectomy to downsize donor lungs for use in small recipients Lau, C.L
2003
22 1S p. S116-S117
2 p.
artikel
255 Localization of TGF-β1 and type II receptor in end stage emphysema of lung transplanted patients Calabrese, F
2003
22 1S p. S138-
1 p.
artikel
256 Long term follow-up of a prospective randomized trial comparing tacrolimus versus cyclosporine in combination with MMF after lung transplantation Zuckermann, A
2003
22 1S p. S76-S77
2 p.
artikel
257 Long-term functional outcome after living-donor lung transplantation in adults Bowdish, M.E
2003
22 1S p. S94-
1 p.
artikel
258 Long-term neuropsychological sequelae of infant cardiac transplant recipients: trends and predictors of outcome Babikian, T.
2003
22 1S p. S144-S145
2 p.
artikel
259 Long-term outcome of coronary artery surgery for ischemic cardiomyopathy - a multi-institutional experience Raman, J
2003
22 1S p. S109-S110
2 p.
artikel
260 Long term results of the domino procedure from cystic fibrosis live donors Aravot, D
2003
22 1S p. S183-
1 p.
artikel
261 Long term survival following left ventricular assist and comprehensive medical management as bridge to recovery therapy for advanced heart failure Silver, M.A
2003
22 1S p. S211-
1 p.
artikel
262 Lung transplantation in infancy Mendeloff, E.N.
2003
22 1S p. S144-
1 p.
artikel
263 Lung transplantation in patients with pulmonary sarcoidosis Milman, N
2003
22 1S p. S189-
1 p.
artikel
264 Lung transplantation in recipients with previous lung volume reduction surgery Lau, C.L
2003
22 1S p. S183-
1 p.
artikel
265 Lung transplantation with donors 60 years of age and older de Perrot, M
2003
22 1S p. S87-
1 p.
artikel
266 Lung Transplant Recipients (LTR) have persistant abnormalities in Bronchoalveolar Lavage(BAL) and endobronchial biopsy(EBB): interim results from a study of RAD vs azathioprine(AZA) Levvey, B.J
2003
22 1S p. S191-
1 p.
artikel
267 LVAD driveline infections in the modern era : incidence risk factors and strategies for reduction Stanford, E.A
2003
22 1S p. S131-
1 p.
artikel
268 Lymphoproliferative disease following lung transplant: postitive results with rituximab as primary therapy Lien, D.C
2003
22 1S p. S160-S161
2 p.
artikel
269 Magnetic resonance measurements of cornary flow reserve: relationship to coronary angiographic findings Kennedy, K
2003
22 1S p. S91-
1 p.
artikel
270 Managing patients with left ventricular assist device at home, results with 37 patient-years of experience Khodaverdian, R
2003
22 1S p. S206-
1 p.
artikel
271 Marginal donors in shortage era: impact on recipient’s long-term outcomes Gambino, A
2003
22 1S p. S116-
1 p.
artikel
272 Maternal and foetal outcome following pregnancy after intrathoracic organ transplantation: single centre experience in 21 patients Nair, K.S
2003
22 1S p. S160-
1 p.
artikel
273 May preservation solution affect the incidence of graft vasculopathy in transplanted heart? Garlicki, M
2003
22 1S p. S76-
1 p.
artikel
274 Measuring physical activity among female heart transplant recipients Evangelista, L.S
2003
22 1S p. S220-
1 p.
artikel
275 Mechanical circulatory assistance with pulsatile or continuous flow devices leads to molecular remodeling of dystrophin: evidence for improvement in the failing left and right ventricle Vatta, M
2003
22 1S p. S219-
1 p.
artikel
276 Mechanical circulatory support of 22 patients with the original uncoated debakey VAD® Wilhelm, M.J
2003
22 1S p. S199-
1 p.
artikel
277 Mechanical support for isolated RV failure in post-cardiotomy patients Moazami, N
2003
22 1S p. S206-S207
2 p.
artikel
278 Medication noncompliance > 1 year after heart transplantation predicts posttransplant outcome: a 5 years follow-up survival analysis study Dobbels, F
2003
22 1S p. S147-S148
2 p.
artikel
279 Medium term results of ECMO for severe acute lung injury following lung transplantation Dahlberg, P.S
2003
22 1S p. S159-S160
2 p.
artikel
280 Microalbuminuria in heart transplant patients: association with the development of allograft vasculopathy Rockx, M.A
2003
22 1S p. S176-
1 p.
artikel
281 MIG/CXCL9 neutralization attenuates chronic rejection of transplanted hearts Whiting, D
2003
22 1S p. S154-
1 p.
artikel
282 Migration of mesenchymal progenitors to heart allograft: evidence for active participation of mesenchymal stem cells in tissue repair and inadvertent attribution to graft fibrosis Wu, G.D
2003
22 1S p. S125-
1 p.
artikel
283 Monocyte-induced endothelial calcium signaling mediates E-selectin and VCAM-1 expression on xenogeneic endothelium Peterson, M.D
2003
22 1S p. S105-
1 p.
artikel
284 Multi-organ transplantation: is there a protective effect against acute and chronic rejection? Pinderski, L
2003
22 1S p. S182-
1 p.
artikel
285 Multiple combination bactericidal testing (MCBT) for patients with multiresistant Pseudomonas aeruginosa undergoing lung transplantation Scott, A.R
2003
22 1S p. S181-
1 p.
artikel
286 Mycophenolate mofetil: clinical applications and pharmacokinetic monitoring in pediatric heart transplant recipients Dipchand, A.I
2003
22 1S p. S134-
1 p.
artikel
287 Mycophenolate mofetil dose and serum level correlation in young cardiac transplant patients Gajarski, R.J
2003
22 1S p. S133-S134
2 p.
artikel
288 Mycophenolate Mofetil (MMF) vs Azathioprine (AZA) in lung transplantation for the prevention of Bronchiolitis Obliterans Syndrome (BOS): results of a 3 year international randomised trial Glanville, A.R
2003
22 1S p. S207-
1 p.
artikel
289 Mycophenolic mofetil reduces the alloimmune response of children to surgical valved allograft implantation Shaddy, R.E
2003
22 1S p. S214-S215
2 p.
artikel
290 Myocardial structural recovery is associated with apoptosis inactivation in biomechanical unloaded heart by LVAD therapy Vatta, M
2003
22 1S p. S210-
1 p.
artikel
291 Myocardial velocity patterns of tissue doppler imaging in pre-terminal heart transplantation in pediatric patients Fyfe, D.A
2003
22 1S p. S172-
1 p.
artikel
292 Natriuretic peptides as predictors of clinical course in patients with end-stage heart failure Potapov, E.V
2003
22 1S p. S206-
1 p.
artikel
293 Natural killer cell-derived cytokines are central in monocyte infiltration and rejection of porcine xenografts Itescu, S
2003
22 1S p. S89-
1 p.
artikel
294 Natural killer cells can mediate cardiac allograft vasculopathy in murine allografts Rose, H.S
2003
22 1S p. S154-
1 p.
artikel
295 Nebulised iloprost in pulmonary arterial hypertension due to eisenmengers syndrome Reichenberger, F
2003
22 1S p. S153-
1 p.
artikel
296 Negative effect of CMV donor status on graft survival after lung but not heart transplantation is restricted to HLA-A2 negative recipients Bonatti, H
2003
22 1S p. S161-
1 p.
artikel
297 Nesiritide use in end stage heart failure Truong, K.M
2003
22 1S p. S110-
1 p.
artikel
298 Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation? Ferrer, E
2003
22 1S p. S217-S218
2 p.
artikel
299 Neutrophil defensin concentrations in pediatric lung transplant recipients Faro, A
2003
22 1S p. S132-
1 p.
artikel
300 New combination of immunosuppressive therapy decreases acute rejection in lung transplantation Bhorade, S.M
2003
22 1S p. S120-
1 p.
artikel
301 Non-invasive molecular screening for acute cardiac rejection: a multicenter prospective clinical study Eisen, H.J
2003
22 1S p. S74-
1 p.
artikel
302 Non-invasive monitoring of acute rejection in heart transplantation: a reappraisal of summated QRS voltage amplitude on ECG Caforio, A.L.P
2003
22 1S p. S173-
1 p.
artikel
303 Non-invasive screening by tissue doppler for late post-transplant cardiac rejection surveillance Dandel, M
2003
22 1S p. S90-S91
2 p.
artikel
304 Normalization of left ventricular size and systolic function after diagnosis of pediatric dilated cardiomyopathy Tsirka, A.E
2003
22 1S p. S136-
1 p.
artikel
305 Novacor left ventricular assist bridge to transplant: no sensitization or excess rejection as compared to unsupported patients Baran, D.A
2003
22 1S p. S195-
1 p.
artikel
306 Novel application of thoratec VAD as a paracorporeal total artificial heart El-Banayosy, A
2003
22 1S p. S198-S199
2 p.
artikel
307 N-terminal brain natriuretic peptide: the new gold standard in predicting mortality in patients with advanced heart failure Gardner, R.S
2003
22 1S p. S85-
1 p.
artikel
308 Obesity and advanced heart failure: the differential impact of body weight on b-type natriuretic peptide and proinflammatory cytokine expression Mehra, M.R
2003
22 1S p. S85-
1 p.
artikel
309 One-year results of an international, randomized, double-blind study of everolimus vs azathioprine as adjunctive therapy to inhibit the decline of pulmonary function in stable lung or heart/lung transplant recipients Snell, G.I
2003
22 1S p. S207-S208
2 p.
artikel
310 Optimal immunosuppression post cardiac transplantation: clinical outcomes of long-term cyclosporine monotherapy in a large patient population Rockx, M.A
2003
22 1S p. S119-
1 p.
artikel
311 Optimization of a novel low-stength electroporation system for ex vivio gene transfer in human heart Sen, L
2003
22 1S p. S106-S107
2 p.
artikel
312 Outcome after cardiac transplantation - influence of allocation modus Costard-Jäckle, A
2003
22 1S p. S209-
1 p.
artikel
313 Outcome of heart transplantation using refurbished allografts Odim, J
2003
22 1S p. S87-
1 p.
artikel
314 Outcomes from 100 patients treated with implantable LVAD therapy: are we ready for destination therapy? Smolens, I.A
2003
22 1S p. S201-S202
2 p.
artikel
315 Oxygenation improvement and pulmonary vasodilation with Nitric Oxide (NO) or alprostadil immediately after lung transplantation Bulpa, P
2003
22 1S p. S186-
1 p.
artikel
316 Oxygen consumption predicts outcomes in lung transplant candidates with pulmonary fibrosis Kawut, S.M
2003
22 1S p. S182-
1 p.
artikel
317 Paraoxonase-1 M55l single nucleotide polymorphism: a new mutation associated with transplant coronary artery disease? Miriuka, S.G
2003
22 1S p. S75-S76
2 p.
artikel
318 Patient adherence at 5 to 6 years after heart transplantation Bellg, A.J
2003
22 1S p. S127-
1 p.
artikel
319 Patient factors influencing waiting time to heart transplant in the UK and Republic of Ireland Hudson, A.J
2003
22 1S p. S217-
1 p.
artikel
320 Perception is deceiving; the real gender specific exercise capacity of heart transplant recipients Cole, B.T
2003
22 1S p. S220-S221
2 p.
artikel
321 Perioperative complications after living-donor lobar lung transplantation Sano, Y
2003
22 1S p. S188-
1 p.
artikel
322 Perioperative use of neseritide in heart failure patients undergoing implantation of left ventricular assist device Radovancevic, B
2003
22 1S p. S201-
1 p.
artikel
323 Pet imaging of [18]-FDG as a non-invasive indicator of infection versus rejection in lung transplant recipients Jones, H.A
2003
22 1S p. S192-
1 p.
artikel
324 Plasma neurohormonal expression in LVAD patients: toward hormone-guided therapeutic assessment Thompson, L.O
2003
22 1S p. S195-S196
2 p.
artikel
325 Poly-ADP-ribose polymerase-inhibition protects against myocardial and endothelial reperfusion injury after heart transplantation Szabo, G.
2003
22 1S p. S143-
1 p.
artikel
326 Post-operative obesity and cachexia are risk factors for post heart transplant morbidity and mortality: a multi-institutional study of post-operative weight change Grady, K.L
2003
22 1S p. S175-
1 p.
artikel
327 Preclinical experience in transplant with lung obtained from non heart beating donors Varela, A
2003
22 1S p. S112-
1 p.
artikel
328 Predicting death following lung transplantation: development of a prognostic model Saeed, I
2003
22 1S p. S93-S94
2 p.
artikel
329 Prediction of maximal lung function in IPF and COPD single lung transplant recipients Ahmad, S
2003
22 1S p. S194-S195
2 p.
artikel
330 Predictors and outcomes of acute humoral rejection treated with plasmapheresis in heart transplant recipients Uber, W.E
2003
22 1S p. S169-
1 p.
artikel
331 Predictors of death on the unos lung transplant waiting list Egan, T
2003
22 1S p. S147-
1 p.
artikel
332 Predictors of poor RV function following LVAD implantation Boyle, A.J
2003
22 1S p. S205-
1 p.
artikel
333 Predictors of quality of life at 5 to 6 years after heart transplantation Grady, K.L
2003
22 1S p. S220-
1 p.
artikel
334 Pre-emptive use of oral valgancyclovir in cardiac recipients Devyatko, E
2003
22 1S p. S123-S124
2 p.
artikel
335 Pre-existing renal failure doubles 30 day mortality after cardiac transplantation Ostermann, M.E
2003
22 1S p. S209-
1 p.
artikel
336 Pre-operative predictors of outcome after VAD: can we predict survivors? Harding, J
2003
22 1S p. S205-
1 p.
artikel
337 Pre-operative renal function and outcomes following orthotopic heart transplantation Odim, J.N.K
2003
22 1S p. S176-
1 p.
artikel
338 Presence of a positive PRA adversely predicts both short and long term survival following heart transplantation Edwards, B.S
2003
22 1S p. S177-S178
2 p.
artikel
339 Presence of donor-derived DNA in the plasma of sex-mismatched cardiac transplant recipients: a potential novel strategy for monitoring graft rejection Woo, K.S
2003
22 1S p. S90-
1 p.
artikel
340 Preservation in microvascular endothelial function despite epicardial endothelial dysfunction in cardiac transplant recipients Kushwaha, S.S
2003
22 1S p. S165-S166
2 p.
artikel
341 Prevalence of gastro-esophageal reflux disease in lung transplant candidates D’Ovidio, F
2003
22 1S p. S187-
1 p.
artikel
342 Prevention of bone loss after cardiac transplantation with alendronate or calcitriol: efficacy and safety Maybaum, S
2003
22 1S p. S156-
1 p.
artikel
343 Prior HLA allosensitization predisposes patients to become and remain highly sensitized after LVAD implantation Drakos, S.G
2003
22 1S p. S205-
1 p.
artikel
344 Profiling the nonadherent adolescent heart transplant recipient Freeman, M.H
2003
22 1S p. S129-
1 p.
artikel
345 Prograf decreases plasma cholesterol in heart transplant recipients with treated but persisting mild dyslipidemia: the canadian multicenter randomized trial of prograf versus neoral White, Michel
2003
22 1S p. S140-
1 p.
artikel
346 Progress towards a more physiologic approach to heart preservation: the advantages of hyperpolarized arrest Diodato, M.D
2003
22 1S p. S103-
1 p.
artikel
347 Prolonged non-invasive ventilatory support prior to pulmonary transplantation does not affect postoperative outcome Castle, H
2003
22 1S p. S189-S190
2 p.
artikel
348 Prospective randomized international multi-center investigator driven study comparing TAC and CSA (+MMF/steroids) after lung transplantation - interim analysis of 110 patients Reichenspurner, H
2003
22 1S p. S77-
1 p.
artikel
349 Prospective short-term pilot study of sirolimus as an induction of immunosuppression in heart transplant recipients Zakliczynski, M
2003
22 1S p. S118-
1 p.
artikel
350 Protective mechanisms of radical scavengers vitamins C&E in an in-vivo pig model of pulmonary reperfusion injury Wagner, F.M
2003
22 1S p. S188-
1 p.
artikel
351 Proteonomic analysis of changes in “total” protein expression during bridge to clinical recovery using left ventricular assisst devices (LVADS) Dunn, M.J
2003
22 1S p. S203-
1 p.
artikel
352 PTLD in a pediatric heart transplant cohort is not associated with traditional risk factors Pahl, E
2003
22 1S p. S134-
1 p.
artikel
353 PX3.102, a novel immunosuppressant, slows tracheal allograft rejection in the mouse model of obliterative bronchiolitis Chalermskulrat, W
2003
22 1S p. S103-
1 p.
artikel
354 QTC interval prolongation predicts mortality in patients with transplant coronary artery disease Vrtovec, B
2003
22 1S p. S208-
1 p.
artikel
355 Quality of life after lung transplantation for lymphangioleiomyomatosis (LAM) Pollock-BarZiv, S.M
2003
22 1S p. S221-
1 p.
artikel
356 Quality of life and left ventricular assist devices: differences between implanted, explanted and transplanted patients Hallas, C.N
2003
22 1S p. S129-
1 p.
artikel
357 Rapamycin-based and late FK506-light immunosuppression in heart transplant recipients Griffith, B.P
2003
22 1S p. S118-
1 p.
artikel
358 Rapamycin (SIROLIMUS) AUC estimation in heart transplant recipients with chronic renal impairment Moloney, E.D
2003
22 1S p. S117-S118
2 p.
artikel
359 Rapid assessment of quality of life in patients with advanced heart failure Baird, B.L
2003
22 1S p. S132-
1 p.
artikel
360 Readmission following discharge on LVAD: implications for permanent support Banbury, M.K
2003
22 1S p. S204-S205
2 p.
artikel
361 Recovery of chronic renal impairment with sirolimus after lung transplantation Venuta, F
2003
22 1S p. S180-
1 p.
artikel
362 Recovery of right ventricular function post lung transplantation in patients with long-term pulmonary hypertension on contemporary vasodilator therapy Jimenez, J
2003
22 1S p. S191-
1 p.
artikel
363 Reduced size lung transplantation - follow up on 27 patients Warnecke, G
2003
22 1S p. S189-
1 p.
artikel
364 Reduction of PECAM-1 at graft endothelium after cardiac transplantation is accompanied by the reduction of leukocyte infiltration into the perivascular space of arteries. a comparative study with CSA, FK506 and MMF Richter, M.H.C
2003
22 1S p. S95-
1 p.
artikel
365 Rejection with hemodynamic compromise: a dismal prognosis Lee, R
2003
22 1S p. S91-
1 p.
artikel
366 Relation between quality of life and functional variables in heart transplant recipients Tegtbur, U
2003
22 1S p. S221-
1 p.
artikel
367 Reliability of the novacor LVAS: implications for destination therapy Livi, U
2003
22 1S p. S196-S197
2 p.
artikel
368 Renal growth after cardiac transplantation in infants Tsirka, A.E
2003
22 1S p. S135-S136
2 p.
artikel
369 Reperfusion with blood at 30 deg C improves heart function after myocardial ischemia/reperfusion (I/R) injury. novel mechanism to enhance donor heart Jayakar, D
2003
22 1S p. S113-
1 p.
artikel
370 Resourse implications of ECMO as a bridge to paediatric heart transplant Whitmore, P
2003
22 1S p. S130-
1 p.
artikel
371 Risk/benefit-based lung allocation algorithms Murray, S.
2003
22 1S p. S128-S129
2 p.
artikel
372 Risk factors for death after lung transplant in the US Egan, T.
2003
22 1S p. S146-S147
2 p.
artikel
373 Role of CMV antigenemia directed preemptive therapy with ganciclovir for the prevention of cmv disease at 6 months in lung transplant recipients Husain, S
2003
22 1S p. S183-S184
2 p.
artikel
374 Role of interleukin-8 in predicting outcome of donor lungs de Perrot, M
2003
22 1S p. S212-
1 p.
artikel
375 Role of the ICOS/ICOS ligand costimulating system in endothelial cell-dependent T cell activation Klingenberg, R
2003
22 1S p. S155-S156
2 p.
artikel
376 Role of the thymus in heterotopic cardiac allograft survival in miniature swine: evidence for the need of thymic emigrants immediately post-transplantation, and thymic immigrants for long term tolerance induction Yamamoto, S
2003
22 1S p. S162-
1 p.
artikel
377 Routine cytopathology testing is unnecessary with bronchoscopy following lung transplantation Wanner, T.J
2003
22 1S p. S181-S182
2 p.
artikel
378 Scientific program 2003
22 1S p. S23-S73
51 p.
artikel
379 Scientific program committee 2003
22 1S p. S2-
1 p.
artikel
380 Scoring of 2,788 endomyocardial biopsies correlate rejection to the development of transplant coronary artery disease after heart transplantation Espejo Vassilakis, M.
2003
22 1S p. S139-
1 p.
artikel
381 Scoring system determines successful RVAD explant following BiVAD support: implications for destination therapy Patel, H.J
2003
22 1S p. S84-
1 p.
artikel
382 Screening potential donors for living donor lobar lung transplantation Schenkel, F.A
2003
22 1S p. S86-S87
2 p.
artikel
383 Screening scale for predicting outcomes in high-risk potential heart transplant candidates under extracorporeral membrane oxygenation Chen, Y.S
2003
22 1S p. S200-S201
2 p.
artikel
384 Sequential expression of three known protective genes in cardiac biopsies after transplantation De Souza, A.I
2003
22 1S p. S163-
1 p.
artikel
385 Serial echocardiography increases donor heart utilization Babcock, W.D
2003
22 1S p. S74-
1 p.
artikel
386 Serious abdominal complications of intra-peritoneal placement of left ventricular assist devices Tansley, P
2003
22 1S p. S202-
1 p.
artikel
387 Short and long term outcomes using marginal pulmonary allograft donors Luckraz, H
2003
22 1S p. S116-
1 p.
artikel
388 Should we transplant UNOS status 2 patients? Jimenez, J.
2003
22 1S p. S146-
1 p.
artikel
389 Significant reduction in major LVAD device failures: comparison of the heartmate® VE and XVE LVAS Pagani, F.D
2003
22 1S p. S204-
1 p.
artikel
390 Simvastatin restores contractile function and reduces cardiac remodeling in cardiomyopathy Osorio, J.C
2003
22 1S p. S107-S108
2 p.
artikel
391 Single cell detection of IFN-gamma production identifies lung recipients at high risk for early immune complications Mohler, K
2003
22 1S p. S99-
1 p.
artikel
392 Single center comparison of pediatric living donor lobar and cadaveric lung transplant Sweet, S.C.
2003
22 1S p. S145-S146
2 p.
artikel
393 Sirolimus in combination with tacrolimus for primary immunosuppression after orthotopic heart transplantation Mueller, M
2003
22 1S p. S118-S119
2 p.
artikel
394 Site of heterotopic tracheal allograft implantation affects graft rejection pattern Sadegh Beigi, F
2003
22 1S p. S104-
1 p.
artikel
395 Sodium-hydrogen exchanger inhibition is superior to pharmacological preconditioning for extended cardiac allograft preservation Ryan, J.B
2003
22 1S p. S113-
1 p.
artikel
396 Specific dysregulation of troponins and inflammatory marker genes in endomyocardial biopsies from heart transplant recipients Kelemen, S.E
2003
22 1S p. S99-
1 p.
artikel
397 Specific gene expression profile associated with ischemia-reperfusion injury during lung transplantation identified by CDNA microarray Yamane, M
2003
22 1S p. S187-
1 p.
artikel
398 Stable left ventricular volumes and function following Dor ventriculoplasty Patel, H.J
2003
22 1S p. S157-S158
2 p.
artikel
399 Statin treatment decreases QTC interval duration and improves survival in heart transplant recipients Vrtovec, B
2003
22 1S p. S174-
1 p.
artikel
400 Stem cells mobilization treatment removing severe congestive heart failure patients from heart transplantation indication- preliminary results Bocchi, E.A
2003
22 1S p. S124-
1 p.
artikel
401 Study of the safety and tolerability of Simulect® (basiliximab) versus OKT3 in heart transplantation Crespo-Leiro, M.G.
2003
22 1S p. S141-
1 p.
artikel
402 Sublingual sildenafil and reversibility of pulmonary hypertension in candidates to heart transplant Gomez Sanchez, M.A
2003
22 1S p. S86-
1 p.
artikel
403 Successful outcome in lung transplant recipients who receive organs from donors with rapid onset fatal asthma Hopkins, P.M.A
2003
22 1S p. S112-
1 p.
artikel
404 Supporters 2003
22 1S p. S13-
1 p.
artikel
405 Surgical risk factor analysis in lung transplantation Muller, L.C
2003
22 1S p. S193-
1 p.
artikel
406 Surveillance Bronchoscopy (SB) in Lung Transplant Recipients (LTR): risk versus benefit? McWilliams, T.J
2003
22 1S p. S190-
1 p.
artikel
407 Survival benefit of heart transplantation in high risk donors and recipients Luckraz, H
2003
22 1S p. S163-S164
2 p.
artikel
408 Survival benefit of lung transplantation in cystic fibrosis patients infected with B. Cepacia Gutierrez, C.A
2003
22 1S p. S93-
1 p.
artikel
409 Survival of lung transplant recipients with bronchiolitis obliterans syndrome Valentine, V.G
2003
22 1S p. S193-S194
2 p.
artikel
410 Survival of lung transplant recipients with Cystic Fibrosis (CF) harboring panresistant bacteria other than B. cepacia, compared to patients harboring sensitive bacteria Hadjiliadis, D
2003
22 1S p. S190-S191
2 p.
artikel
411 Switch from euro-collins® to perfadex® for pulmonary graft preservation resulted in superior outcome in transplant recipients Rega, F
2003
22 1S p. S111-
1 p.
artikel
412 Tacrolimus in heart transplantation: monotherapy vs. steroid requiring patients Galin, I.D
2003
22 1S p. S150-
1 p.
artikel
413 Tacrolimus: in vitro effects on neutrophil production and apoptosis Koenig, J.M
2003
22 1S p. S96-
1 p.
artikel
414 Temporal alteration in B-type natriuretic peptide expression predicts allograft failure in heart transplantation Park, M.H
2003
22 1S p. S156-S157
2 p.
artikel
415 Ten year experience with human lung transplantation from non-heart beating donors Love, R.B
2003
22 1S p. S87-
1 p.
artikel
416 Ten year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptor Wabbijn, M
2003
22 1S p. S121-S122
2 p.
artikel
417 The change of ultrasonic tissue characterization with integrated backscatter is a significant marker to diagnose cardiac allograft vasculopathy Nunoda, S
2003
22 1S p. S170-
1 p.
artikel
418 The contribution of blood product transfusions to HLA allosensitization in LVAD recipients Drakos, S.G
2003
22 1S p. S197-S198
2 p.
artikel
419 The differences in hemodyanamics, cardiac function and myocardial structure associated with chronic mechanical circulatory in patients support with either pulsatile or continuous flow left ventricular assist devices Thohan, V
2003
22 1S p. S219-
1 p.
artikel
420 The differential impact of spironolactone on patterns of pro-inflammatory cytokine expression in advanced heart failure Becker, J.R
2003
22 1S p. S108-
1 p.
artikel
421 The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation van Besouw, N.M
2003
22 1S p. S167-S168
2 p.
artikel
422 The effect of oversizing cardiac allografts on survival in pediatric patients with congenital heart disease Razzouk, A.J.
2003
22 1S p. S145-
1 p.
artikel
423 The effect on microvascular function of combined mechanical circulatory support and pharmacological therapy during induction of myocardial recovery Tansley, P
2003
22 1S p. S196-
1 p.
artikel
424 The efficacy of partial liquid ventilation on lung protection during hypotension and cardiac arrest Sekine, Y
2003
22 1S p. S114-
1 p.
artikel
425 The hub-and-spoke sysytem in treating acute cardiogenic shock: who survives? Kherani, A.R
2003
22 1S p. S198-
1 p.
artikel
426 The impact of a positive donor-specific crossmatch on outcome after heart transplantion Schmitz, S.S
2003
22 1S p. S91-S92
2 p.
artikel
427 The impact of induction therapy and the donor specific crossmatch on outcome after heart transplantation Devyatko, E
2003
22 1S p. S169-
1 p.
artikel
428 The impact of pharmacogenomic factors on steroid weaning in pediatric heart transplant patients using logistic regression analysis Zheng, H.X.
2003
22 1S p. S141-
1 p.
artikel
429 The intrinsic mitochondrial oxidative capacity of the failing heart is depressed and relates to markers of disease severity Mettauer, B
2003
22 1S p. S108-
1 p.
artikel
430 The Micromed-Debakey VAD: initial american experience Goldstein, D.J
2003
22 1S p. S218-
1 p.
artikel
431 The predictive value of bronchiolitis obliterans syndrome stage 0-p Hachem, R.R
2003
22 1S p. S78-
1 p.
artikel
432 The prostacycline derivative “ILOPROST” as an additive to low potassium dextran (LPD) preservation solution improves early graft function following porcine lung transplantation after 24 hours of cold ischemia Gohrbandt, B
2003
22 1S p. S110-S111
2 p.
artikel
433 Therapy of erectile dysfunction by sildenafil (viagra) in patients after orthotopic heart transplantation Deyerling, K.W
2003
22 1S p. S166-
1 p.
artikel
434 Therapy with prostanoids and transplantation in patients with primary pulmonary hypertension Dandel, M
2003
22 1S p. S184-
1 p.
artikel
435 The right ventricular response to pulmonary hypertension is related to left ventricular mass Saba, T
2003
22 1S p. S179-S180
2 p.
artikel
436 The risk of bronchiolitis obliterans syndrome is reduced in lung transplant patients who receive mycophenolate mofetil based immunosuppression Dunitz, J.M
2003
22 1S p. S151-
1 p.
artikel
437 The risk of thromboembolism with the novacor left ventricular assist device Rogers, J.G
2003
22 1S p. S202-
1 p.
artikel
438 The risk of transmission of hepatitis B from from donors with hepatitis B core antibody positivity is low Pinney, S.P
2003
22 1S p. S213-
1 p.
artikel
439 The role of epithelial cell apoptosis in allograft transplant-induced airway obliteration Segall, L.E
2003
22 1S p. S99-S100
2 p.
artikel
440 The role of poly(ADP)ribose synthetase in lung ischemia-reperfusion injury Woolley, S.M.
2003
22 1S p. S142-S143
2 p.
artikel
441 The safety and efficacy of bosentan in pulmonary hypertension due to congenital heart disease Benza, R.L
2003
22 1S p. S152-
1 p.
artikel
442 The tolerability and efficacy of total lymphoid irradiation (TLI) in the control of rapidly progressive bronchiolitis obliterans syndrome Fisher, A.J
2003
22 1S p. S151-S152
2 p.
artikel
443 The use of bosentan and a prostacyclin analog in the treatment of primary pulmonary hypertension Rayburn, B.K
2003
22 1S p. S152-
1 p.
artikel
444 The utility of CMV hyper immunoglobulin in the treatment of CMV mismatch lung transplant recipients Malouf, M.A
2003
22 1S p. S191-S192
2 p.
artikel
445 Time course of physical reconditioning during exercise rehabilitation late after heart transplantation Tegtbur, U
2003
22 1S p. S216-
1 p.
artikel
446 Time-dependent mortality risk of heart transplantation compared with remaining on the waitlist Merion, R.M
2003
22 1S p. S147-
1 p.
artikel
447 Time-dependent mortality risk of lung transplantation compared with remaining on the waitlist McCullough, K.P.
2003
22 1S p. S146-
1 p.
artikel
448 Tissue doppler echocardiography - new insights into cardiac allograft function in children Pauliks, L.B
2003
22 1S p. S214-
1 p.
artikel
449 Tissue doppler echocardiography predicts positive left ventricular remodeling after biventricular pacing in severe heart failure Penicka, M
2003
22 1S p. S159-
1 p.
artikel
450 To induce or not to induce: current assessment of perioperative immunosuppression practices and outcome in heart transplantation Higgins, R
2003
22 1S p. S176-
1 p.
artikel
451 Tolerability of carvedilol in children with severe heart failure referred to a transplantation centre Ford, K.A
2003
22 1S p. S135-
1 p.
artikel
452 Total artificial heart bridge to transplantation: a 9 year experience in 61 patients Copeland, J.G
2003
22 1S p. S148-
1 p.
artikel
453 Transcriptional profiling of the vascular smooth muscle cell response to allograft injury Absaieri, M.V
2003
22 1S p. S101-
1 p.
artikel
454 Transplantation of a mixed population of bone marrow-derived progenitor cells improves regional systolic function in a rabbit model of cryoinjured myocardium Thompson, R.B
2003
22 1S p. S80-
1 p.
artikel
455 Transplantation using hearts from primary pulmonary hypertensive donors for recipients with high pulmonary vascular resistance Birks, E.J
2003
22 1S p. S156-
1 p.
artikel
456 Tricuspid regurgitation after cardiac transplantation: how many biopsies are too many? Nguyen, V
2003
22 1S p. S171-S172
2 p.
artikel
457 Two-year experience with continuous subcutaneous treprostinil (prostacyclin stable analogue) in severe pulmonary hypertension treatment Ruiz-Cano, M.J
2003
22 1S p. S180-
1 p.
artikel
458 Unexpected role for HO-1 in the clinical heart transplant setting Holweg, C
2003
22 1S p. S164-
1 p.
artikel
459 Utility of B-type natriuretic peptide in cardiac transplant evaluation Bhat, G
2003
22 1S p. S174-
1 p.
artikel
460 Utility of neurohumoral profiles in pulmonary hypertension: clinical and hemodynamic correlations Frantz, R.P
2003
22 1S p. S153-S154
2 p.
artikel
461 Utility of the natriuretic peptides, ANP and BNP in the diagnosis of impaired cardiac function in organ donors Nyawo, B
2003
22 1S p. S115-S116
2 p.
artikel
462 Vascular endothelial growth factor gene polymorphism are associated with acute rejection after heart transplantation Datta, S
2003
22 1S p. S163-
1 p.
artikel
463 Vascularized thymic lobe transplantation: experience with an allogeneic and xenogeneic large animal model of transplantation Vagefi, P.A
2003
22 1S p. S89-
1 p.
artikel
464 Vascular thrombosis in patients with long term Jarvik 2000 VAD support Delgado, R.M
2003
22 1S p. S218-
1 p.
artikel
465 Visualization of alloreactive CD4 T cell responses and tolerance induction in vivo Sandner, S
2003
22 1S p. S161-S162
2 p.
artikel
466 What contributes to emotional distress in female heart transplant recipients? Gerard, I
2003
22 1S p. S131-S132
2 p.
artikel
467 Which heart transplant recipients are likely to survive more than 10 years? Segovia, J
2003
22 1S p. S166-
1 p.
artikel
468 Yield of surveillance and diagnostic transbronchial lung biopsies (TBB) performed beyond one year after lung transplantation Wennström, R.
2003
22 1S p. S139-
1 p.
artikel
                             468 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland